Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

World Biopharmaceutical Contract Manufacturing (BCMO) Market 2012-2022 by Type of Service, Organization and Regions - Research and Markets

Research and Markets
Posted on: 05 Dec 17

The "Biopharmaceutical Contract Manufacturing (BCMO) Market - by Type of Service, by Organization and by Region" report has been added to Research and Markets' offering.

How Large is the Biopharmaceutical Contract Manufacturing Opportunity? Will the Drive for New Biopharma Last? Who are the Key Players in this Industry?

These are among the questions answered by report on biomanufacturing organizations, labelled BCMOs. The market for biopharmaceutical manufacturing is driven by many factors - an aging population, demand for more effective solutions to disease, and the expiration of blockbusters.

Over the past several years, an unprecedented number of blockbuster drugs have lost patent protection, and this trend is expected to continue through the foreseeable future. Because generic medicines are priced at a discount of up to 90% of the cost of the original drug, yet are considered therapeutically identical, their growing usage represents a particularly threat to blockbuster drugs. Yet pharmaceutical companies cannot always produce their needed pipeline in-house. This has created an ideal market environment for biopharmaceutical contracting.

This report, Biopharmaceutical Contract Manufacturing Market ( BCMOs) Markets by Type of Service, CMO and Region, contains the following market information:

  • BCMO Market 2012-2022
  • Top Company Revenues
  • BCMO Country Markets (U.S., Western Europe, Eastern Europe, China, India, Other Asia, Latin America, Rest of World)
  • BCMO Market by Segment (Clinical Manufacturing, Commercial Manufacturing)
  • Company Profiles
  • Preferred Vendor Relationships, CMO M&A, Big Pharma in CM, Vertical Integration and Other Important Trends

Key Topics Covered:

1: Executive Summary

2: Overview

3: The Contract Manufacturing Industry

4: The BCMO Market In The U.S. And Western Europe

5: The BCMO Market In The Emerging Regions

6: Total Global Bcmo Market

7: Issues And Trends

8: Pharmaceutical & Biotech Company Profiles

  • 3P Biopharmaceuticals
  • Abbvie
  • Asahi Glass Co.
  • Avara Pharmaceutical Services
  • Baxter Biopharma Solutions
  • Boehringer Ingelheim Bioxcellence
  • Catalent
  • Celonic AG
  • Cytovance Biologics
  • DM Bio
  • Dr. Reddy'S Laboratories
  • Glaxosmithkline Biopharmaceuticals
  • Grifols
  • Idifarma
  • Jubilant Life Sciences
  • Juniper Pharmaceutical Services
  • Kemwell Biopharma
  • Patheon/Thermo Fisher Scientific
  • Pfizer Centreone
  • Piramal
  • Recipharm
  • Rentschler Biotechnologie Gmbh
  • Rovi Contract Manufacturing
  • Samsung Biologics
  • Siegfried AG
  • Sl Pharma Labs
  • Strides Shashun Ltd.
  • Symbiosis Pharmaceutical Services
  • Syngene International
  • TCG Lifesciences
  • Teuto
  • Therapure Biopharma
  • Wuxi Apptec

For more information about this report visit

View source version on

Business Wire

Last updated on: 05/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.